ANGIOMAX, created in 1999 (United States), from 2951 sister brands and 17477 competing brands. ANGIOMAX is a brand of NOVARTIS N, listed on the stock exchange of Zurich. Its International Securities Identification Number (ISIN) is CH0012005267. The sector of ANGIOMAX is Drug Manufacturers.
Investment simulator :
Portfolio valuation
NOVARTIS N
(ANGIOMAX)
over 5 years*
CHF 95.61